Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 15;13(7):1373.
doi: 10.3390/v13071373.

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems

Affiliations
Review

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems

Sergey Brezgin et al. Viruses. .

Abstract

Viral infections cause a variety of acute and chronic human diseases, sometimes resulting in small local outbreaks, or in some cases spreading across the globe and leading to global pandemics. Understanding and exploiting virus-host interactions is instrumental for identifying host factors involved in viral replication, developing effective antiviral agents, and mitigating the severity of virus-borne infectious diseases. The diversity of CRISPR systems and CRISPR-based tools enables the specific modulation of innate immune responses and has contributed impressively to the fields of virology and immunology in a very short time. In this review, we describe the most recent advances in the use of CRISPR systems for basic and translational studies of virus-host interactions.

Keywords: CHIKV; CRISPR/Cas; DNA sensors; EBOV; HBV; HCV; HDV; HIV; HSV; KSHV; SARS-CoV-2; Toll-like receptor; ZIKV; cGAS/STING; epitranscriptomics; influenza A virus; interferon effector proteins; interferon induction; interferon stimulated genes; pathogen recognition receptor; pathogen-associated molecular pattern; pooled libraries; yellow fever virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Sensing of foreign nucleic acids. (A) TLR- and RLR-mediated sensing of foreign nucleic acids. Different types of cytoplasmic foreign RNA are recognized by RIG-I or MDA5 sensors followed by activation of MAVS and downstream TBK1-IRF signaling. In endosomes, RNA and CpG-DNA activate TLRs that result in one of the two signaling pathways involving TRIF or MYD88-IRAK. Activation of IRFs induces the expression of interferons and mRNA of pro-inflammatory factors. (B) Cytoplasmic and nuclear sensors of foreign DNA. Cytoplasmic DNA can be sensed by a number of sensors, including IFI16, cGAS, and AIM2. The first two factors activate the STING pathway that ultimately induces TBK1/IRF and interferon secretion. Upon recognition of cytoplasmic DNA, AIM2 induces caspase-1-dependent maturation of pro-IL-1β (pro-inflammatory response). A2B1 (hnRNPA2B1) and IFI16, among other factors, can participate in the sensing of foreign DNA in the nuclei of cells. IFI16 interferes with foreign nuclear DNA by epigenetic silencing, whereas A2B1 recognizes foreign DNA as well as activates and enhances innate antiviral responses. This picture was created in BioRender. Abbreviation: A2B1—hnRNPA2B1; m6a—methyl-6-adenine RNA; ER—endoplasmic reticulum.
Figure 2
Figure 2
Restriction of viral life cycle by different ISGs for viruses with nuclear replication. ISGs with antiviral activity are shown for different steps of viral replication, including binding and viral entry, capsid disassembly, nuclear import, reverse transcription, viral nucleic acid replication/transcription, nuclear export, translation, capsid assembly, budding and release of viral particles. This picture was created in BioRender.
Figure 3
Figure 3
Mechanisms of viral immune evasion. (A) Evasion of immune recognition. (B) Blockade of interferon signaling. This picture was created in BioRender. Abbreviations: NA—nucleic acids; ISG—interferon-stimulated genes; IFNs—interferons; PTM—post-transcriptional modifications; SOCS—suppressor of cytokine signaling.
Figure 4
Figure 4
General pipeline of pooled CRISPR screens. (1) In silico design of sgRNA targeting regulatory elements (promoters and/or enhancers) of target genes (or in genome-wide format). In modern pooled libraries, four to 10 different sgRNAs are designed to target a single regulatory element, which constitutes up to 200,000 sgRNAs in a single genome-wide library. (2) Lentiviral delivery of CRISPR pooled library into cells expressing appropriate Cas protein (Cas9 for knockout screens and dCas9 for activation of interference screens) into infected cells at low MOI (to ensure delivery of a single sgRNA into a single cell). (3) Selection of transduced cells (negative or positive). Note that knockdown of genes (KO) is relevant for nucleolytic Cas systems and base editors, whereas CRISPRa and CRISPRi systems cause the overexpression or suppression of gene transcription, correspondingly. (4) Enrichment of cells. (5) Isolation of nucleic acids from the bulk of enriched cells. (6) Deep sequencing and identification of hits by determining sgRNAs representation in the material. This picture was created in BioRender.

References

    1. Sayed A., Peng B. Pandemics and income inequality: A historical review. SN Bus. Econ. 2021;1:1–17. doi: 10.1007/s43546-021-00059-4. - DOI - PMC - PubMed
    1. World Health Organization . Global Hepatitis Report. World Health Organization; Geneva, Switzerland: 2017.
    1. GBD 2016 Mortality Collaborators Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1084–1150. doi: 10.1016/S0140-6736(17)31833-0. - DOI - PMC - PubMed
    1. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interf. Cytokine Res. 2004;24:439–454. doi: 10.1089/1079990041689665. - DOI - PubMed
    1. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 1999;17:189–220. doi: 10.1146/annurev.immunol.17.1.189. - DOI - PubMed

Publication types